Thermo Fisher Scientific ROA 2010-2022 | TMO

Current and historical return on assets (ROA) values for Thermo Fisher Scientific (TMO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Thermo Fisher Scientific ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2022-09-30 $7.03B $90.54B 7.62%
2022-06-30 $7.44B $90.58B 8.45%
2022-03-31 $7.60B $92.75B 9.24%
2021-12-31 $7.73B $95.12B 10.22%
2021-09-30 $8.57B $73.60B 12.40%
2021-06-30 $8.60B $67.70B 12.89%
2021-03-31 $7.92B $65.93B 12.16%
2020-12-31 $6.38B $69.05B 10.06%
2020-09-30 $4.88B $64.06B 8.04%
2020-06-30 $3.71B $61.59B 6.30%
2020-03-31 $3.67B $58.69B 6.33%
2019-12-31 $3.70B $58.38B 6.47%
2019-09-30 $3.59B $56.73B 6.34%
2019-06-30 $3.54B $57.97B 6.30%
2019-03-31 $3.17B $55.60B 5.71%
2018-12-31 $2.94B $56.23B 5.26%
2018-09-30 $2.57B $55.08B 4.59%
2018-06-30 $2.39B $55.40B 4.26%
2018-03-31 $2.25B $56.58B 4.18%
2017-12-31 $2.23B $56.67B 4.33%
2017-09-30 $2.33B $55.99B 4.78%
2017-06-30 $2.27B $46.51B 4.86%
2017-03-31 $2.17B $46.21B 4.76%
2016-12-31 $2.02B $45.91B 4.52%
2016-09-30 $2.00B $48.01B 4.58%
2016-06-30 $2.00B $42.25B 4.78%
2016-03-31 $1.99B $42.95B 4.78%
2015-12-31 $1.98B $40.83B 4.77%
2015-09-30 $1.97B $41.15B 4.71%
2015-06-30 $1.97B $41.77B 4.66%
2015-03-31 $1.74B $41.86B 4.05%
2014-12-31 $1.90B $42.85B 4.31%
2014-09-30 $1.64B $42.69B 3.97%
2014-06-30 $1.48B $44.31B 3.94%
2014-03-31 $1.48B $46.13B 4.42%
2013-12-31 $1.27B $31.86B 4.42%
2013-09-30 $1.31B $28.27B 4.72%
2013-06-30 $1.28B $27.63B 4.65%
2013-03-31 $1.24B $27.41B 4.54%
2012-12-31 $1.18B $27.45B 4.35%
2012-09-30 $1.09B $27.58B 4.05%
2012-06-30 $1.07B $26.36B 3.98%
2012-03-31 $1.35B $26.82B 5.17%
2011-12-31 $1.33B $26.83B 5.25%
2011-09-30 $1.34B $26.99B 5.58%
2011-06-30 $1.34B $24.07B 5.93%
2011-03-31 $1.06B $23.43B 4.82%
2010-12-31 $1.04B $21.35B 4.83%
2010-09-30 $1.01B $21.54B 4.70%
2010-06-30 $0.96B $21.28B 4.48%
2010-03-31 $0.93B $21.63B 4.35%
2009-12-31 $0.85B $21.63B 3.99%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $216.198B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $47.210B 32.49
Alcon (ALC) Switzerland $33.483B 28.83
STERIS (STE) Ireland $18.026B 22.43
Teleflex (TFX) United States $10.579B 17.16
Fresenius Medical Care AG KGaA (FMS) Germany $9.137B 9.17
Penumbra (PEN) United States $7.442B 1781.27
Globus Medical (GMED) United States $7.143B 36.31
Integer Holdings (ITGR) United States $2.386B 19.15
Glaukos (GKOS) United States $2.248B 0.00
Nevro (NVRO) United States $1.572B 0.00
Paragon 28 (FNA) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.248B 17.77
Artivion (AORT) United States $0.525B 0.00